All subjects in this study were treated with KA TKA.
All information obtained from this study was treated with confidentiality.
All animals included in this study were treated in accordance with the guidelines from the Danish Inspectorate of Animal Experimentation.
The conclusion drawn from this study indicated that patients with IED who were treated with systemic IS were not at an increased risk of death from malignancy.
This study retrospectively analyzed all patients with GBM who were treated with at least one cycle of BEV and FTM from July 2010 to October 2012.
Women with vault prolapse (greater than or equal to stage 2) were treated with abdominal sacrocolpopexy and were excluded from this study.
Children with acute malaria were treated with Coartem™ and excluded from the study.
In this study, 12 patients were treated with Dynesys and 21 patients were treated with DTL.
For time course studies, cells were treated with NEU for different time periods ranging from 0 to 120 minutes.
Successful completion of this study provides genome-wide expression data from >100 patients who were treated with erlotinib.
For the current proteomic study, tissue was included from 16 men who were treated with radiation plus androgen deprivation [ 2].
